Andras  Szasz,
Towards the Immunogenic Hyperthermic Action: Modulated ElectroHyperthermia
Clinical Oncology and Research
2020
2613-4942
http://dx.doi.org/10.31487/j.COR.2020.09.07
https://www.sciencerepository.org/towards-the-immunogenic-hyperthermic-action-modulated-electro-hyperthermia_COR-2020-9-107 
Abstract: Hyperthermia treatment for solid tumors is a long-used, but poorly accepted method in clinical use.
Modulated electro-hyperthermia (mEHT, trade name: oncothermia®) changes the paradigm, introduces a
novel, cellularly selective and immunogenic cell-ruination. The mEHT method produces tumor-vaccination,
presenting the unharmed genetic information of cancer cells to immune cells [1]. The mEHT method is
approved in more than 30 countries. Its phase II/III clinical applications indicate a broad perspective.Keywords: Hyperthermia, oncology, immunogenic cell death